Brief: VIB And Surface Oncology Announce Publication In Cell Reports Revealing Il-27 Structure And The Mechanism Of Action For Srf388
19/10/2022 12:23
Oct 19 (Reuters) - Surface Oncology Inc SURF.O :
* VIB AND SURFACE ONCOLOGY ANNOUNCE PUBLICATION IN CELL
REPORTS
REVEALING IL-27 STRUCTURE AND THE MECHANISM OF ACTION FOR SRF388
* SURFACE ONCOLOGY INC - FINDINGS SUPPORT ONGOING CLINICAL
INVESTIGATION OF SRF388
* SURFACE ONCOLOGY INC - STUDY ELUCIDATES HOW SRF388 BINDS
TO
IL-27 TO PREVENT INTERACTION WITH IL-27 RECEPTOR
Source text for Eikon: ID:nGNX1v09GD
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing